For almost two decades, 12-month DAPT in ACS has been the only class I recommendation on DAPT in American and European guidelines, despite the lack of prospectively established evidence. Several subsequent studies questioned the 12-month regimen and suggested that DAPT duration

⁦Paris 2024⁩ #olympics

10K final ⁦Paris 2024⁩

Publication of #Insilico trial emulation to predict the cardiovascular protection of new lipid-lowering drugs: an illustration through the design of the #SIRIUS programme in EJPC Editor-in-Chief Pr Franck BOCCARA Cardiology Ph.Gabriel Steg Guillaume Mahé MDPhD Nova In Silico track.smtpsendmail.com/9032119/c?p=aB…

⁦Víkingur Ólafsson⁩ @tacaksgabor #laroquedantheron #schumann a stunning performance !

#Provence

In-silico trial emulation to predict the cardiovascular protection of new lipid-lowering drugs: an illustration through the design of the SIRIUS programme Find the open access to our publication in #EJPC #Insilicotrial #SiriusTrial #Lipids ttps://doi.org/10.1093/eurjpc/zwae254

Je propose de bien commencer la semaine par un déluge de beauté picturale, avec une sélection d’œuvres du peintre japonais Hasui Kawase (1883 - 1957), connu essentiellement pour ses paysages. Thread 🎨 Kawase Hasui - Lune de printemps à Ninomiya

Very proud of the entire ABYSS team ACTION for this great achievement ! AP-HP NEJM European Society of Cardiology nejm.org/doi/full/10.10…

proud that @vincentalgalarrondo and the CERAMIC team Hôpital Bichat - Claude-Bernard AP-HP authored and contributed to testing this new treatment for transthyretin amyloidosis

RHEIA Trial: women w/ severe AS, TAVI using SAPIEN 3/SAPIEN 3 Ultra superior to surgery for primary composite end point of death, stroke, or rehospitalization at one year: superiority driven by lower rate of rehospitalizations. #ESC2024 #ESCCongress2024 European Society of Cardiology

Asundexian 50 mg inferior to Apixiban for stroke prevention ⁦European Society of Cardiology⁩ #ESCCongress

Team #MINT with FOUR presentations at #ESC2024! Transfusion in MI: -#CHF outcomes -4-Hgb-level simulated transfusion -6-month outcomes -individual-patient meta-analysis European Society of Cardiology JACC Journals Ph.Gabriel Steg

🚨 SENIOR-RITA trial: in older patients with NSTEMI, an invasive strategy did not result in a lower risk of CV death or MI than a conservative approach 😷 1518 patients >75 y/o randomized to coronary angiography and revascularization or medical therapy #ESCCongress2024

🌕🌃 Quand la vasque s'élève et se reflète dans la Seine ça donne ce genre d'images sublimes ! On ne s'en lasse pas 😍 - 🌕🌃 When the vasque rises and reflects in the Seine, it creates these stunning images! We can’t get enough of it 😍 🎥 #Paris2024

congrats Tabassome SIMON Shaun Goodman Renato D. Lopes #transfusion #RCTs

Congrats Tabassome SIMON for your @ESCCongress2024 presentation of MINT 6 month outcomes today in #London

Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes... sciencedirect.com/science/articl…

Enjoyed presenting at #ESCCongress in London ✨SCORED - Sotagliflozin improves HF outcomes with increasing benefit for longer diabetes duration ✨REDUCE-IT sdLDL-C - icosapent ethyl improves CV outcomes irrespective of baseline small dense LDL ✨NHANES V1P - Enrollment

Do you have a manuscript you're looking to submit? #AHAJournals will consider your original article submission in any format, as long as all files are provided? #ESCCongress Learn more about our format-free submission guidance in our new Author Hub: ahajrnls.org/3Z3qp5a